Silvercrest Asset Management Group LLC Cuts Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Silvercrest Asset Management Group LLC reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 97.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,189 shares of the medical instruments supplier's stock after selling 1,557,136 shares during the period. Silvercrest Asset Management Group LLC's holdings in DENTSPLY SIRONA were worth $782,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Treasurer of the State of North Carolina raised its stake in DENTSPLY SIRONA by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after buying an additional 560 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. Blue Trust Inc. raised its position in shares of DENTSPLY SIRONA by 10.9% during the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock worth $137,000 after acquiring an additional 707 shares in the last quarter. Quarry LP raised its position in shares of DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after acquiring an additional 780 shares in the last quarter. Finally, Federated Hermes Inc. lifted its stake in DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock worth $3,213,000 after purchasing an additional 915 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded down $0.38 during mid-day trading on Monday, hitting $15.47. 2,475,144 shares of the company's stock were exchanged, compared to its average volume of 2,968,748. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $28.25. The business's 50 day moving average is $14.47 and its two-hundred day moving average is $17.08. The firm has a market capitalization of $3.08 billion, a P/E ratio of -7.47, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the prior year, the business earned $0.42 EPS. The firm's revenue was down 7.8% compared to the same quarter last year. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.14%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Mizuho dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Barrington Research upped their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Finally, UBS Group dropped their price objective on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $20.36.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.